These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7223763)

  • 1. Case study: complications associated with anticoagulant therapy.
    Davis GL; Mutnick AH
    Am J Med Technol; 1981 Mar; 47(3):179-82. PubMed ID: 7223763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
    Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute adrenal hemorrhage complicating anticoagulant therapy.
    O'Connell TX; Aston SJ
    Surg Gynecol Obstet; 1974 Sep; 139(3):355-7. PubMed ID: 4850407
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy.
    Blackshear JL; Baker VS; Holland A; Litin SC; Ahlquist DA; Hart RG; Ellefson R; Koehler J
    Arch Intern Med; 1996 Mar; 156(6):658-60. PubMed ID: 8629878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatory treatment without complications. A 1-year experience in distal deep-vein thrombosis].
    Svensson P; Lethagen S; Lindén E; Berntorp E
    Lakartidningen; 1994 Aug; 91(34):2950-2. PubMed ID: 7990537
    [No Abstract]   [Full Text] [Related]  

  • 9. [Warfarin in the treatment of antiphospholipid syndrome].
    Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
    Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis and anticoagulant therapy.
    Sullano MA; Ortiz EJ
    Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 14. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW; Pellegrini VD; Leibert KM; Totterman S; Azodo MV; Harris CM; Cox C; Marder VJ
    Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation and improvement program for inpatient anticoagulant control.
    Phillips WS; Smith J; Greaves M; Preston FE; Channer KS
    Thromb Haemost; 1997 Feb; 77(2):283-8. PubMed ID: 9157582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulant treatment of acute deep venous thrombosis].
    Marques JS
    Phlebologie; 1973; 26(3):291-304. PubMed ID: 4790971
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.